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Abstract: An 11-year-old intact female chow chow dog was presented for evaluation of intermittent vomiting and anorexia for a month.
On ultrasonographic examination, gastric pylorus hypertrophy which compressed common bile duct was identified. The gallbladder
was significantly enlarged and mucocele was suspected. Cholecystectomy and gastric full thickness biopsy were performed and gastric
adenocarcinoma was diagnosed by histopathological examination. Billroth II gastrojejunostomy using thoracoabdominal-stapler (TAstapler) was performed. On surgery, hypertrophied tissue suspected of tumour was also found adjacent to the major duodenal papilla.
After surgery, vomiting disappeared, and the patient regained appetite. On postoperative day 90, the patient was presented vomiting and
jaundice again. On ultrasonography, the common bile duct was dilated and a narrowing of diameter was identified adjacent to major
duodenal papilla. Biliary stenting with double wired nitinol uncovered stents was performed. On abdominal radiography, the diameter
of bile duct stricture region was increased 7 days postoperatively. The patient had no complications related to biliary stent and died of
gastric adenocarcinoma 1 year postoperatively.
Keywords: Billroth II gastrojejunostomy, double wired nitinol biliary stent, malignant extrahepatic biliary obstruction, gastric
adenocarcinoma, dog

1. Introduction
Gastric neoplasm in dogs is uncommon [1]. Gastric
adenocarcinoma accounts for 60% to 70% of canine gastric
cancer, and is usually located along the pyloric antrum
or lesser curvature [2]. Clinical signs include chronic
intermittent vomiting or regurgitation which responds
poorly to symptomatic treatment due to gastric or outflow
obstruction [1].
Billroth II gastrojejunostomy, commonly performed
in humans, is a bypass operation. The distal stomach is
resected and the stump above is anastomosed laterally
to the jejunum, and the proximal end of the duodenum
is closed [3,4]. In dogs, Billroth II gastrojejunostomy is
performed infrequently, probably because practitioners
lack surgical experience with this technique, and the
incidence of gastric tumour or ulcer is low [4].
In gastric neoplasia, extrahepatic biliary obstruction
may occur if the tumour externally compresses the
adjacent common bile duct or major duodenal papilla
[3]. Biliary stent may be used to dilate the obstructed
biliary tract, thereby semipermanently resolving the
obstruction without changing hepatobiliary anatomy. In
human medicine, biliary stent is widely used to stabilize

patients before biliary surgery, to manage short or longterm obstructive biliary disease and pancreatitis-induced
stricture of the common bile duct, and for palliation
of malignancies [5,6]; it has not yet commonly used in
veterinary medicine.
We report a successful Billroth II gastrojejunostomy
for gastric adenocarcinoma in a dog, with application of
a double-wire uncovered nitinol stent to resolve tumorinduced EHBO. To our knowledge, this technique has not
been previously reported in the veterinary literature.
2. Case history
An 11-year-old spayed female chow chow breed dog was
presented for evaluation of intermittent vomiting and
anorexia over the previous month. Serum biochemistry
revealed elevation of liver enzyme level including alanine
aminotransferase (391 U/L (reference range from 10–100
U/L)), aspartate aminotransferase (86 U/L (0–50 U/L)),
alkaline phosphatase (over 2000 U/L (23–212 U/L)), and
gamma glutamyltransferase (9 U/L (0-7 U/L)). Elevation
of C-reactive protein was also identified (53 mg/L (0–35
mg/L)). On ultrasonography, the gallbladder was severely
distended with sludge, and a kiwi-like pattern was partially
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identified (Figure 1a). The pylorus region showed diffuse
thickening of mucosa layer of the gastric wall (Figure 1b)
and a polyp. gastric full-thickness biopsy was performed
to identify the cause of gastric wall thickening. Digital
palpation during surgery confirmed pyloric stenosis,
and gastric outflow was compromised. To relieve this,
Y-U pyloroplasty was performed after the biopsy.
Since the gallbladder was significantly enlarged and we
suspected mucocele, we also performed cholecystectomy.
On histopathological examination, the thickened
gastric wall was diagnosed as gastric adenocarcinoma.
Histopathological findings of malignancy prompted us to
plan surgical wide resection of the tumour. On computed
tomography with heterogeneous contrast-enhancement,
rarely-marginated focal wall thickenings were detected
in the gastric pylorus. Peripheral lymph nodes including
gastric, hepatic and pancreaticoduodenal lymph nodes
were enlarged, but no lung metastasis was detected.
Billroth II gastrojejunostomy using a TA-stapler was
planned. Atropine sulphate (0.04mg/kg subcutaneously),
cefazolin (30mg/kg intravenously [IV]), and butorphanol
(0.1mg/kg IV) were used as anaesthesia premedication.
Anaesthesia was induced with propofol (4mg/kg IV), and
maintained with isoflurane (2%) in oxygen.
A ventral midline abdominal incision from the xiphoid
process to the pubis was performed. The abdominal wall
was retracted using a Balfour retractor, and the stomach
was isolated. The pyloric portion showed diffuse thickening
of the wall, and was abnormally firm when palpated. We
noted hypertrophied tissue, suspected of malignancy,
extending to the duodenum adjacent to the location of the

major duodenal papilla. Stay sutures were placed on the
gastric body, pyloric antrum, and duodenum; we ligated
and transected the vascular branches of the right and left
gastroepiploic arteries between the pylorus and the point
opposite the incisura angularis on the greater curvature.
The greater omentum in the region to be removed was
then resected close to the greater curvature. We ligated and
transected the branches of the right and left gastric arteries
supplying from the pylorus to the incisura angularis on
the lesser curvature. We transected the hepatoduodenal
ligament of the site to be removed, to permit manipulation
of the duodenum. During transection, care was taken to
prevent damage to the common bile duct, portal vein,
and hepatic artery. The duodenal portion was clamped
with Doyen intestinal forceps and transected (Figure
2a). Closure of the gastric stump at the incisura angularis
was achieved with 2 rows of 90-mm length TA-stapler
(Raloadable staplers, Medtronic, Minneapolis, USA)
with 3.5 mm cartridge. Closure of the entrance to the
duodenum was performed with a 2-layer suture pattern.
The mucosa and submucosa were closed with simple
continuous suture using 3-0 monofilament absorbable
sutures (Maxon; Covidien, Minneapolis, MN, USA)
(Figure 2b); a simple interrupted suture pattern was then
placed in the seromuscular layer. The residual gastric stump
was finished with a simple continuous pattern using 3-0
polyglyconate sutures (Maxon; Covidien). The proximal
jejunal loop was then attached to the visceral surface of
the stomach body via the antecolic, isoperistaltic route.
The seromuscular layer of the proximal jejunum, just distal
to the duodenum, was sutured to the gastric stump body

Figure 1. Ultrasonographic images of a gallbladder (a) stomach (b) of a dog with intermittent vomiting and anorexia. (a) Accumulation
of gravity-dependent sludge (*) is visible, with partial kiwi-like pattern (arrow) in gallbladder lumen. (b) The overall gastric wall of the
pylorus region is diffusely thickened to > 6 mm (arrow heads).
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near the greater curvature of the stomach using a simple
continuous pattern to reduce tension. A full-thickness
3-cm-long longitudinal incision was made just below the
previous seromuscular layer suture into the body of the
stomach. After insertion of stay sutures to secure the site,
a corresponding incision was made in the antimesenteric
surface of the jejunum adjacent to the seromuscular
layer suture (Figure 2c). Gastro-jejunal anastomosis was
performed in a side-to-side fashion (Figure 2d). The
mucosa and submucosa of the stomach were sutured to the
corresponding layers of the jejunum in a simple continuous

pattern using 3-0 polyglyconate sutures. The seromuscular
layers of the stomach and jejunum were then sutured in a
simple continuous pattern parallel to and just below the
incision line, for relief of tension. Omentalization was
performed over the anastomotic site. The abdomen was
flushed several times with sterile warm normal saline and
closed routinely.
After the surgery, vomiting disappeared and the
patient recovered appetite. However, on postoperative day
90, the patient resumed vomiting and showed jaundice
with yellow skin and conjunctiva. Serum biochemistry

Figure. 2. Intraoperative photographs illustrating the Billroth II gastrojejunostomy procedure using TA stapler. The top of each
photograph is cranial, and the bottom caudal (Gs: gastric stump, D: duodenum, J: jejunum). (a) 2 rows of 90 mm length TA-stapler with
a 3.5 mm cartridge is used for the closure of the gastric stump at the incisura angularis. The duodenal portion is clamped with Doyen
intestinal forceps and transected. (b) The entrance to the duodenum is closed with a 2-layer suture pattern. Simple interrupted suture
using 3-0 monofilament absorbable sutures is placed in the seromuscular layer of the jejunum. (c) A full-thickness longitudinal incision
is made into the body of the stomach (*) and the corresponding incision is made in the antimesenteric surface of the jejunum (X). (d)
Then the gastro-jejunal anastomosis is performed in a side-to-side fashion, and omentalization is performed over the anastomotic site
(arrow head).
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revealed elevation of liver enzyme levels, including
alkaline phosphatase (over 2000 U/L (23–212 U/L)),
gamma glutamyltransferase (25 U/L (0–7 U/L)), and total
bilirubin (9 mg/dL (0–0.9 mg/dL)). On ultrasonography,
the common bile duct was dilated to a maximum of 11.6
mm (Figure 3a), and narrowed in diameter to 1 mm
adjacent to the edematous major duodenal papilla (Figure
3b). Palliative biliary stenting using the double-wire nitinol
uncovered biliary stent was performed to alleviate clinical
signs. During surgery, we observed that the common
bile duct was tortuous and dilated. Duodenotomy on the
antimesenteric border was performed over the anticipated
location of the major duodenal papilla, which was then
conspicuous due to oedematous change. A 6 Fr feeding
tube was inserted through the major duodenal papilla
to secure the common bile duct. After removal of the
feeding tube, a stent mounted on a 6 Fr guide wire was
inserted through the major duodenal papilla. Two stents
with a diameter of 10 mm and a length of 40 mm were
overlapped, but the distal end of this enlarged stent failed
to reach the duodenal lumen. Therefore, one more stent
with a diameter of 10 mm and a length of 60 mm was
placed and sutured to the duodenal submucosa using 3-0
non-absorbable sutures (Dafilon; B. Braun, Melsungen,
Germany) (Figure 4). For postoperative antibiotic medical
treatment, we administered cefotaxime (30mg/kg IV),
enrofloxacin (5mg/kg subcutaneously), metronidazole
(15mg/kg IV) for 2 weeks. Metoclopramide (0.3m/kg,
IV) was administered for 2 weeks to prevent vomiting.

For postoperative analgesia, a continuous rate infusion of
butorphanol (0.2mg/kg/h) was administered for 24 h after
surgery, then oral tramadol (5mg/kg) twice daily for 7 days.
Liver supplements including ursodeoxycholic acid (7.5mg/
kg orally) were prescribed for 5 months. Immediately
after surgery, the serum total bilirubin level decreased to
5.7 mg/dL (0–0.9 mg/dL), and by postoperative day 14
had decreased further to within the normal range (0.5
mg/dL). Postoperative abdominal radiography showed
that the diameter of the bile duct stricture had increased
to 10 mm 7 days postoperatively (Figure 5). The patient
died of gastric adenocarcinoma 1 year postoperatively. No
complications related to gastric flow obstruction or the
biliary stent, including stent migration and obstruction,
were identified until death.
3. Results and discussion
Complete surgical resection is a therapeutic option for
gastric adenocarcinoma, but extensive gastric involvement
of the neoplasia often hampers complete excision [2]. Such
cases require wide ablation and bypass procedures, such as
gastrojejunostomy or gastroduodenostomy [7]. In humans,
Billroth II gastrojejunostomy is commonly performed
for severe gastric or duodenal ulcer, or distal gastric
neoplasia [4]. However, in dogs the incidence of gastric
tumour is lower than among humans, and the technical
challenges of Billroth II surgery limit its application in
veterinary medicine. Generally, prognosis of the Billroth
II gastrojejunostomy is poor due to complications such

Figure 3. Ultrasonographic images of common bile duct (a) and major duodenal papilla (b) of the patient on postoperative day 90. (a)
The common bile duct is dilated to a maximum of 11.6 mm (arrow heads), with narrowing to 1 mm is identified adjacent to the major
duodenal papilla. (b) Oedematous major duodenal papilla (6 × 10 mm) is visible (*).
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Figure 4. Intraoperative photographs illustrating biliary stenting
using the double-wire nitinol uncovered biliary stent. Note the
part of biliary stent (10 × 60 mm) residing in the duodenum.

as stomal ulceration and rapid passage of food [3,4,8].
Although the Billroth II procedure immediately alleviates
gastric outflow obstruction and results in clinical
improvement during the initial postoperative period,
it requires extensive surgery with difficult and delicate
surgical techniques [8]. In the present case, neoplasia was
extensively involved in the gastric pylorus region and the
proximal duodenal region adjacent to major duodenal
papilla. Therefore, despite the high likelihood of a poor
prognosis, we chose the Billroth II gastrojejunostomy rather
than simple gastrectomy or Billroth I gastroduodenostomy
to maximize removal of neoplastic tissue.
Some surgical considerations may increase the
likelihood of success. The presence of residual gastric
antrum after Billroth II gastrojejunostomy, stomal diameter,
and the length of the afferent intestine loop are important
indicators of the likely success of this surgery [4]. Complete
resection of the gastric antrum prevents excessive gastric
acid secretions from causing stomal ulceration in the
gastrojejunostomy junction [4,8,9]. Moreover, the size
of the stab incision for stoma formation is an important
prognostic factor: a stomal diameter of 2.1 to 2.3 cm is
ideal, but if exceeds 3 cm then persistent vomiting is likely
[4]. In humans, “dumping syndrome” caused by rapid
passage of ingesta from the stomach to the intestine is a
common side effect when stomal diameter exceeds 2.8 cm
[10]. We performed a 3-cm incision, the highest margin
that would not cause persistent vomiting, and were satisfied
that no relevant clinical signs were detected. Conversely,
a small stab incision may cause stoma constriction and
stenosis. The length of the afferent loop should be as short
as possible without tension, approximately 25 cm in dogs.
Long afferent loops may show “afferent loop syndrome”
including gastrointestinal symptoms such as abdominal

pain, nausea and vomiting; short afferent loop may cause
side effects such as loop twisting [4]. In the present case,
the gastric antrum was completely resected to minimize the
above complications and we carefully assessed the tension
between the afferent loop and the stomach during surgery.
Through the above processes, we obtained a successful
Billroth II surgery outcome in this case.
Malignant EHBO may be due to extrinsic compression,
adjacent inflammation, direct tumour invasion, fibrotic
formation from tumours or, more commonly, a combination
of these factors [11]. In the present case, we considered
extrinsic compression by the gastric adenocarcinoma
invading the common bile duct adjacent to the major
duodenal papilla to be the cause of EHBO. A biliary
stent to dilate the obstructed biliary tract, and surgical
diversion of bile flow may be considered in malignant
EHBO [3,12]. The case we report showed malignant EHBO
caused by extrinsic compression and tumour invasion of
gastric adenocarcinoma, but we did not consider bile flow
diversion because the patient had previously undergone
cholecystectomy due to mucocele. Instead, we chose biliary
tract dilation using the double-wire nitinol uncovered
biliary stent. In patients with EHBO caused by primary
tumours, this technique can relieve hyperbilirubinemia
and clinical signs, improving metabolic and nutritional
status [13].
Biliary stenting is commonly employed for the treatment
of extrahepatic biliary obstruction caused by malignancies
and pancreatitis in humans [11] In the veterinary literature
to date, there are few case reports that discuss the use of
biliary stent as a palliative therapy for the management of
biliary tract disease [12, 14–17] Recent use of choledochal
tube stenting in dogs was successful for decompression
of the biliary tract: red rubber catheters were used in 10
dogs. Nine dogs survived without recurrence of EHBO or
other complications [5]. Tube stents of different diameters
may be selected to fit the common bile duct with differing
degrees of stenosis and in different-sized individuals, and
are easy to remove after placement. However, the risks of
occlusion due to biliary sludge, and stent migration, are
higher for tube than for metallic stents [5,18]. Metallic
stents are retained for longer when the neoplasia is in
the distal portion of the bile duct, but are difficult to be
removed once placed. Also, use of uncovered metallic
stents may lead to mucosal hyperplasia, tissue ingrowth, or
tumour invasion. In our patient, we identified tumour as
the cause of EHBO, obviating the need for later removal of
the stent. We also considered prevention of stent migration
and re-obstruction more important than tissue ingrowth,
and accordingly chose the metallic rather than the tube
stent.
The use of uncovered self-expanding wire mesh
stents within the canine biliary tract has been reported
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Figure 5. Radiologic images of biliary stent immediate after surgery (a,b), postoperative day 30 (c,d), and postoperative day 60 (e,f).
Note the biliary stent is fully expanded to diameter of 10 mm (arrow heads). Complications related to the biliary stent, such as stent
migration, breakage or folding were not identified until the patient’s death from the tumour.
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experimentally in 8 mongrel dogs [19]. Although these
authors identified mild to moderate cellular infiltration
and mucosal hyperplasia of the bile duct, all stents
remained patent in the common bile duct for 30 to 90 days.
An investigation of the utility of the metal expandable
biliary endoprosthesis in a canine biliary duct for safe
relief of biliary obstruction reported microscopic, minimal
amounts of necrotic tissue adjacent to the compression
sites due to this stent [13], and identified focal fibrosis and
chronic inflammation of the submucosa, and thickening of
the ductal wall. However, hyperbilirubinemia and icterus
due to biliary obstruction improved considerably over
up to 6 months, without stent migration. Together, the
above studies support use of the metallic biliary stent for
palliative decompression of malignant EHBO, because of
the considerable capacity of this prosthesis for relieving
obstruction with a relatively low complication rate.
In our case, Billroth II gastrojejunostomy was performed
prior to biliary stenting due to the gastric neoplasia. This
prevented intestinal contents from passing around the
major duodenal papilla, an important consideration for
prevention of the retrograde cholangitis that is a major
complication of the biliary stent.
Comparisons between surgical bypass and application
of uncovered nitinol stents for palliative treatment in
malignant EHBO patients have been clinically attempted
in humans [20], suggesting that the effectiveness of biliary
decompression and mean survival time were similar
between surgical bypass such as cholecystoenterostomy
or choledochoduodenostomy, and application of biliary

stents. Whereas the biliary stent has fewer early stage
complications and faster recovery, surgical bypass probably
results in lower recurrent rates in the long-term. This study
concluded that patients not eligible for curative resection
may be managed better with biliary stenting, whereas
surgical bypass is more appropriate for patients with
prognoses of longer survival. Generally, the prognosis of
gastric adenocarcinoma is poor. After the onset of clinical
signs in untreated dogs, the median survival time is less
than 3 months, and when following tumour excision, the
median survival time is less than 8 months [3,12]. We were
unable to resect the gastric adenocarcinoma completely,
because it had spread to the region adjacent to the major
duodenal papilla, with strong indications of metastasis to
the gastric, hepatic and pancreaticoduodenal lymph nodes
on CT examination. Consequently, the likely survival time
of our patient was considered to be short. Our patient also
underwent prior cholecystectomy to remove the mucocele.
However, even if the gallbladder is present, biliary stent
with its associated lower early stage complication rate and
more rapid recovery, should be considered as a palliative
treatment alternative to surgical bypass.
The results of our case report demonstrate that in cases
of diffuse gastric pylorus neoplasia and the associated
EHBO, Billroth II gastrojejunostomy and biliary stenting
can be performed safely and successfully, emerging as a
promising palliative approach for malignant EHBO.
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